Alvin Shih

EVP of Research & Development, Travere Therapeutics, Inc.

Companies

Oaktree Acquisition Corp. III Life SciencesBoard member Oct 23, 2024 to now¹
ZEVRA THERAPEUTICS, INC.Board member Feb 2, 2024 to now²
Travere Therapeutics, Inc.EVP of Research & Development Jun 11, 2014 to Sep 2, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ZEVRA THERAPEUTICS, INC. ZVRA20,000 shares⁴$203.4K at $10.17Sep 12, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 12, 2025Bought 20,000 shares at $7.89 of ZEVRA THERAPEUTICS, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROaktree Acquisition Corp. III Life Sciences, Board member
2
SEC EDGARZEVRA THERAPEUTICS, INC., Board member
3
SEC EDGARTravere Therapeutics, Inc., EVP of Research & Development
4
SEC EDGARZEVRA THERAPEUTICS, INC. shares after the filing of Sep 12, 2025